These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 37175935)

  • 1. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.
    Bivona G; Iemmolo M; Ghersi G
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives.
    Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
    Lee S; Xu G; Jay TR; Bhatta S; Kim KW; Jung S; Landreth GE; Ransohoff RM; Lamb BT
    J Neurosci; 2014 Sep; 34(37):12538-46. PubMed ID: 25209291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.
    Mecca C; Giambanco I; Donato R; Arcuri C
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
    Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
    Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of CX3CR1 impairs the internalization of Tau by microglia.
    Bolós M; Llorens-Martín M; Perea JR; Jurado-Arjona J; Rábano A; Hernández F; Avila J
    Mol Neurodegener; 2017 Aug; 12(1):59. PubMed ID: 28810892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
    Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
    Front Immunol; 2019; 10():2780. PubMed ID: 31849963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.
    Pawelec P; Ziemka-Nalecz M; Sypecka J; Zalewska T
    Cells; 2020 Oct; 9(10):. PubMed ID: 33065974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer's Disease Patients but Not in Non-Alzheimer's Disease Dementia.
    Bivona G; Iemmolo M; Piccoli T; Agnello L; Lo Sasso B; Ciaccio M; Ghersi G
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease.
    Camacho-Hernández NP; Peña-Ortega F
    Neural Plast; 2023; 2023():4637073. PubMed ID: 36644710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation.
    Chidambaram H; Das R; Chinnathambi S
    Cell Biosci; 2020; 10():109. PubMed ID: 32944223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline.
    González-Prieto M; Gutiérrez IL; García-Bueno B; Caso JR; Leza JC; Ortega-Hernández A; Gómez-Garre D; Madrigal JLM
    Glia; 2021 Jan; 69(1):73-90. PubMed ID: 32662924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa.
    Zabel MK; Zhao L; Zhang Y; Gonzalez SR; Ma W; Wang X; Fariss RN; Wong WT
    Glia; 2016 Sep; 64(9):1479-91. PubMed ID: 27314452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases.
    Subbarayan MS; Joly-Amado A; Bickford PC; Nash KR
    Pharmacol Ther; 2022 Mar; 231():107989. PubMed ID: 34492237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
    Luo P; Chu SF; Zhang Z; Xia CY; Chen NH
    Brain Res Bull; 2019 Mar; 146():12-21. PubMed ID: 30496784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage.
    Sheridan GK; Murphy KJ
    Open Biol; 2013 Dec; 3(12):130181. PubMed ID: 24352739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X
    Suresh P; Phasuk S; Liu IY
    Tzu Chi Med J; 2021; 33(1):1-6. PubMed ID: 33505871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effect of Fractalkine on Radiation-induced Brain Injury Through Promoting the M2 Polarization of Microglia.
    Wang J; Pan H; Lin Z; Xiong C; Wei C; Li H; Tong F; Dong X
    Mol Neurobiol; 2021 Mar; 58(3):1074-1087. PubMed ID: 33089423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
    Puntambekar SS; Moutinho M; Lin PB; Jadhav V; Tumbleson-Brink D; Balaji A; Benito MA; Xu G; Oblak A; Lasagna-Reeves CA; Landreth GE; Lamb BT
    Mol Neurodegener; 2022 Jun; 17(1):47. PubMed ID: 35764973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.